When it comes to sterile products for highly sensitive working areas, BGS is indispensable. Therefore, Germany’s leading provider in the industrial sterilisation of medical products and lab diagnostics amongst other things is, with the help of its beta and gamma rays, once again firmly established at the Compamed in Düsseldorf. From November 18 – 21, 2019, BGS will provide information in Hall 08B, Stand 8BK16 about the capacity expansion that is being realised in Bruchsal with the reconstruction of the gamma facility; it will also provide advice to manufacturers of medical products concerning validation issues.
“In view of the medical-technical progress and the demographic development in the next years, the medical technology sector is and will remain an extremely successful growth and labour market,” comments Dr. Andreas Ostrowicki. “Without doubt, the demand for health care services and thus for medical products will continue to increase worldwide. According to estimates of the Federal Ministry of Health, there are already approximately 400,000 different medical products at present. Needless to say, the corresponding sterilisation capacities have to keep up with this strong growth. BGS already invested in the expansion of facilities at a very early stage and is optimally equipped to support the market growth of the next years,”
Ostrowicki continues to explain. With the commissioning of the new gamma radiation facility, the company was already able to expand capacities for its customers to 80,000 palettes of sterile goods per year. In total, BGS operates two gamma plants and eight electron accelerators at three locations in Germany (Wiehl, Bruchsal, Saal). In these plants, medical products such as syringes, cannulas, catheters, and joint prostheses can be directly sterilised in the packaging within the shortest time and are ready for immediate use afterwards.
Based on the projected increase of sterile medical products, the topics of double qualification and back-up solutions for manufacturers of medical products will become even more significant in the future according to managing director Ostrowicki. “In the context of risk assessment, every manufacturer should ask himself what would happen if there was a shutdown in the plant commissioned with the sterilisation services. We, at BGS, have been following up on the “principle of redundancy” for years. For example, each of our three locations is in a position to assume the processes of the other locations, by means of which the failure safety in production can be significantly increased,” explains Dr. Andreas Ostrowicki. Given this fact, the company once again regards itself as a solution provider at the Compamed this year and is available to answer the questions of manufacturers amongst others, giving them advice about issues relating to validation.
About the Compamed:
The Compamed trade fair in Düsseldorf is the international specialist trade fair for the medical supply industry and product development. In two trade fair halls with exhibition space of over 13,000 sqm, more than 750 exhibitors from 40 countries are expected to participate in 2019. Amongst the focus areas at the trade fair are high-tech solutions, raw materials and precursors, structural elements, components and sub-products for medical devices, technical equipment and technologies for producing medical devices, packaging and services, micro systematics, and nanotechnology as well as contract manufacturing “Electronic Manufacturing Services” (EMS), and complex OEM partnerships. In addition, international speakers and leading experts will participate in forums that present current trends in medical technology. The Compamed takes place at the same time as the Medica – the world’s largest medical trade fair. More information about the Compamed is available at https://www.compamed-tradefair.com/.